Discovery defines the life sciences. Every breakthrough begins with a hypothesis rigorously tested, challenged, and proven. Nothing advances without evidence. Data is scrutinized. Results are verified. Certainty is earned.
For years, however, IT security operated on a very different principle: trust first, verify later. Once inside the network, users and systems were granted broad freedom—a model that once worked but no longer fits today’s reality.
Modern life sciences environments are far too distributed for inherited trust to be safe. Research now spans cloud platforms, on-premises data centers, contract research organizations (CROs), and global partner networks. Data flows faster and farther than ever before. The gap between how science pursues truth and how organizations protect it has grown dangerously wide.
The latest discovery many leaders are making isn’t about molecules or therapies—it’s trust itself. In today’s connected research ecosystem, permanent trust is not a safeguard; it’s a vulnerability.
Zero Trust architecture aligns the rigor of science with the rigor of security—proving, again and again, that validation should never be optional.
Traditional perimeter-based security was built for a simpler world. Systems lived in centralized data centers, users worked from predictable locations, and external access was limited and infrequent. Defend the boundary, the thinking went, and the interior could be trusted. Life sciences organizations no longer operate that way.
Today’s environments include:
In this reality, the perimeter does not fail loudly—it fails quietly. A compromised credential, often obtained through phishing or a third‑party breach, can provide access far beyond its original intent. According to IBM, the average cost of a data breach in life sciences reached $4.61 million in 2025, making it one of the most expensive industries for breaches.¹ In many cases, attackers remain undetected for months, moving laterally through “trusted” systems long after the initial compromise.
The discovery isn’t that breaches happen—it’s that trust persists far longer than it should.
Zero Trust reframes security around a more realistic assumption: breaches will occur, credentials will be compromised, and every access attempt must be continuously verified.
Instead of asking whether a user is inside the network, Zero Trust evaluates each request through the lens of identity, context, and risk.
Key questions become: Who is requesting access? What are they trying to reach? From which device and location? Has anything changed—risk signals, behavior, or posture—since the last verification?
Research shows that breaches significantly erode customer and partner confidence, while strong security programs support behaviors such as data sharing and repeat engagement.² For life sciences leaders, this reframing turns Zero Trust into a leadership‑level risk decision, not a technical upgrade. It directly supports outcomes that matter in the boardroom:
This shift is becoming more urgent as environments grow more complex. Gartner predicts that more than 50% of organizations will fail to achieve expected outcomes from their multi-cloud strategies by 2029, most often due to governance and security gaps rather than technology limitations.3
Organizations that remain anchored to perimeter-centric security consistently encounter the same recurring issues:
Meanwhile, the attack surface continues to expand. Statista reports approximately 22 billion connected devices worldwide in 2025, with the total number expected to roughly double again over the following decade.4 Each additional endpoint—especially Internet of Things (IoT) and operational technology (OT) in labs and manufacturing—introduces new exposure, and breaches involving these environments have been shown to increase average incident costs by six-figure amounts.5
Zero Trust does not require dismantling existing environments. The most effective programs adopt it incrementally, starting where risk is highest and expanding with intent.
This phased approach aligns with federal and industry guidance, including NIST SP 800-207 (Zero Trust Architecture) and CISA’s Zero Trust Maturity Model, both of which emphasize identity, segmentation, and continuous verification as foundational controls.6,7
Zero Trust only succeeds when it reflects how life sciences organizations truly operate: under regulatory pressure, across complex third-party ecosystems, and with minimal tolerance for downtime or disruption.
NexusTek helps life sciences organizations turn Zero Trust from theory into an operational model. Working with executive, IT, security, and compliance stakeholders, NexusTek helps:
The result is security that adapts as environments evolve—without adding friction to critical scientific work.
Life sciences thrive by questioning every assumption and validating what withstands scrutiny. Apply that same discipline to security.
Zero Trust security delivers a straightforward yet transformative principle: trust must be earned continuously, never granted by default. Forward-thinking organizations don’t sacrifice speed for safety—they extend science’s rigor to cybersecurity, ensuring innovation, compliance, and protection advance as one.
Take the first step today: Contact NexusTek for a no-obligation Zero Trust maturity assessment tailored to life sciences. Let’s align your security with the precision your discoveries demand.
IBM, Cost of a Data Breach Report 2025, July 2025
Forrester, The Business Of Zero Trust Security, accessed February 2026
Gartner, Gartner Identifies the Top Trends Shaping the Future of Cloud, May 2025
Statista, Number of IoT Connected Devices Worldwide, 2025
IBM, Cost of a Data Breach Report 2025, July 2025
NIST, SP 800-207: Zero Trust Architecture, August 2020 – April 2024
CISA, Zero Trust Maturity Model, Version 2.0, August 2021 – April 2023